Cite

HARVARD Citation

    Zhou, Y. et al. (2020). Clinical and molecular characteristics associated with survival among cancer patients receiving first-line anti-PD-1/PD-L1-based therapies. Biomarkers. pp. 441-448. [Online]. 
  
Back to record